CorMedix Inc (NASDAQ: CRMD) on Tuesday, plunged -4.30% from the previous trading day, before settling in for the closing price of $12.32. Within the past 52 weeks, CRMD’s price has moved between $3.61 and $17.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 29.80%. The company achieved an average annual earnings per share of 435.24%. With a float of $65.96 million, this company’s outstanding shares have now reached $67.71 million.
The extent of productivity of a business whose workforce counts for 65 workers is very important to gauge. In terms of profitability, gross margin is 95.19%, operating margin of 17.53%, and the pretax margin is 20.81%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CorMedix Inc is 2.75%, while institutional ownership is 35.10%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 435.24% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
CorMedix Inc (CRMD) is currently performing well based on its current performance indicators. A quick ratio of 3.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 1.69 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
The latest stats from [CorMedix Inc, CRMD] show that its last 5-days average volume of 3.72 million was superior to 1.73 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 3.81%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 52.32%, which indicates a significant increase from 1.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 117.25% in the past 14 days, which was higher than the 99.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.17, while its 200-day Moving Average is $10.27. Now, the first resistance to watch is $12.13. This is followed by the second major resistance level at $12.47. The third major resistance level sits at $12.68. If the price goes on to break the first support level at $11.59, it is likely to go to the next support level at $11.38. The third support level lies at $11.04 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
Market capitalization of the company is 799.65 million based on 67,825K outstanding shares. Right now, sales total 43,470 K and income totals -17,930 K. The company made 39,080 K in profit during its latest quarter, and 20,640 K in sales during its previous quarter.
